TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Apiam Animal Health Ltd. ( (AU:AHX) ) is now available.
Apiam Animal Health Ltd. experienced a challenging FY25, with overall financial results falling below expectations due to underperformance in its Clinical Vet Services segment, which constitutes 75% of the company’s revenue. Despite achieving some growth in Intensive Animal Services and implementing efficiency initiatives, the company faced revenue pressures and a statutory net loss following the divestment of Agnes Banks Equine Clinic. In response, a leadership change was made, appointing Bruce Dixon as Interim Managing Director and implementing a Strategic Reset Program to realign the business for sustainable returns.
The most recent analyst rating on (AU:AHX) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Apiam Animal Health Ltd. stock, see the AU:AHX Stock Forecast page.
More about Apiam Animal Health Ltd.
Apiam Animal Health Ltd. operates in the veterinary services industry, focusing on Clinical Veterinary Services and Intensive Animal Veterinary services. The company provides a network of clinics and specialized services for various animals, with a significant market focus on clinical vet services and intensive animal care.
Average Trading Volume: 397,106
Technical Sentiment Signal: Buy
Current Market Cap: A$158.2M
Learn more about AHX stock on TipRanks’ Stock Analysis page.